Genscript Biotech Corporation (HKG: 1548)
Hong Kong
· Delayed Price · Currency is HKD
10.92
-0.08 (-0.73%)
Nov 12, 2024, 4:08 PM HKT
Genscript Biotech Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 399.3 | 1,446 | 1,024 | 1,181 | 629.06 | 252.4 | Upgrade
|
Short-Term Investments | 1,328 | 376.22 | 228.89 | 222.53 | 137.46 | 148.69 | Upgrade
|
Trading Asset Securities | 151.29 | 105.65 | 210.82 | 2.21 | 5.87 | 25.43 | Upgrade
|
Cash & Short-Term Investments | 1,879 | 1,928 | 1,464 | 1,406 | 772.38 | 426.52 | Upgrade
|
Cash Growth | -12.27% | 31.74% | 4.13% | 82.00% | 81.09% | -24.46% | Upgrade
|
Accounts Receivable | 130.81 | 218.83 | 104.28 | 142.44 | 141.75 | 73.07 | Upgrade
|
Other Receivables | 103.68 | 80.66 | 66.13 | 22.46 | 20.32 | 12.8 | Upgrade
|
Receivables | 234.53 | 299.53 | 170.44 | 166.58 | 164.49 | 87.87 | Upgrade
|
Inventory | 50.86 | 53.35 | 59.94 | 44.36 | 31.75 | 16.49 | Upgrade
|
Prepaid Expenses | 11.58 | 1.99 | 2.13 | 5.48 | 3.68 | 1.85 | Upgrade
|
Restricted Cash | 9.64 | 33.07 | 27.2 | 1.44 | 7.47 | 0.97 | Upgrade
|
Other Current Assets | 28.7 | 36.91 | 41.53 | 15.49 | 13.41 | 20.35 | Upgrade
|
Total Current Assets | 2,214 | 2,353 | 1,765 | 1,639 | 993.17 | 554.05 | Upgrade
|
Property, Plant & Equipment | 813.72 | 728.73 | 624.67 | 486.91 | 379.23 | 265.63 | Upgrade
|
Long-Term Investments | 96.73 | 85.41 | 16.03 | 18.47 | 13.99 | 7.28 | Upgrade
|
Goodwill | 1.35 | 1.36 | 2.55 | 14.15 | 14.12 | 15.25 | Upgrade
|
Other Intangible Assets | 16.08 | 18.65 | 23.81 | 26.42 | 26.02 | 25.48 | Upgrade
|
Long-Term Accounts Receivable | 0.23 | 0.29 | 0.4 | - | - | - | Upgrade
|
Long-Term Deferred Tax Assets | 15.13 | 16.51 | 15.05 | 5.09 | 3.7 | 5.7 | Upgrade
|
Other Long-Term Assets | 174.31 | 183.26 | 98.93 | 43.77 | 17.17 | 16.03 | Upgrade
|
Total Assets | 3,332 | 3,387 | 2,546 | 2,234 | 1,447 | 889.41 | Upgrade
|
Accounts Payable | 59.21 | 39.96 | 55.76 | 30.18 | 23.38 | 17.63 | Upgrade
|
Accrued Expenses | 188.69 | 164.77 | 210.03 | 156.11 | 114.4 | 89.15 | Upgrade
|
Short-Term Debt | 31.02 | 56.94 | 33.23 | - | 44.06 | 16.46 | Upgrade
|
Current Portion of Long-Term Debt | - | 0.07 | 0.45 | 0.52 | 0.58 | 0.55 | Upgrade
|
Current Portion of Leases | 14.46 | 8.87 | 11.1 | 7.51 | 2.59 | 1.77 | Upgrade
|
Current Income Taxes Payable | 15.58 | 18.13 | 16.15 | 15.72 | 3.53 | 2.85 | Upgrade
|
Current Unearned Revenue | 122.96 | 98.58 | 44.33 | 35.47 | 84.79 | 60.22 | Upgrade
|
Other Current Liabilities | 101.08 | 107.49 | 174.93 | 167.79 | 54.58 | 35.89 | Upgrade
|
Total Current Liabilities | 533 | 494.81 | 545.98 | 413.31 | 327.91 | 224.51 | Upgrade
|
Long-Term Debt | 846.15 | 712.72 | 567.23 | 381.86 | 1.26 | 1.75 | Upgrade
|
Long-Term Leases | 97.6 | 63.91 | 44.01 | 27.35 | 6.51 | 3.61 | Upgrade
|
Long-Term Unearned Revenue | 2.7 | 47.96 | 2.01 | 15.54 | 288.55 | 281.67 | Upgrade
|
Long-Term Deferred Tax Liabilities | 7.51 | 5.62 | 8.01 | 7.73 | 7.03 | 5.58 | Upgrade
|
Other Long-Term Liabilities | 20.71 | 17.93 | 16.48 | 0.4 | 0.55 | - | Upgrade
|
Total Liabilities | 1,508 | 1,343 | 1,184 | 846.18 | 631.82 | 517.11 | Upgrade
|
Common Stock | 2.13 | 2.12 | 2.11 | 2.1 | 1.95 | 1.88 | Upgrade
|
Additional Paid-In Capital | 1,975 | 1,939 | 1,473 | 1,274 | 1,067 | 368.78 | Upgrade
|
Retained Earnings | -772.84 | -597.73 | -502.25 | -275.4 | -175.01 | 29.94 | Upgrade
|
Treasury Stock | -8.31 | -9.45 | -11.92 | -15.75 | -16.71 | -7.77 | Upgrade
|
Comprehensive Income & Other | 19.28 | 56.87 | 49.57 | 60.78 | 24.92 | -10.02 | Upgrade
|
Total Common Equity | 1,215 | 1,391 | 1,011 | 1,046 | 901.71 | 382.8 | Upgrade
|
Minority Interest | 609.29 | 653.28 | 352.13 | 341.7 | -86.11 | -10.51 | Upgrade
|
Shareholders' Equity | 1,824 | 2,044 | 1,363 | 1,388 | 815.59 | 372.3 | Upgrade
|
Total Liabilities & Equity | 3,332 | 3,387 | 2,546 | 2,234 | 1,447 | 889.41 | Upgrade
|
Total Debt | 989.23 | 842.5 | 656.02 | 417.24 | 55 | 24.13 | Upgrade
|
Net Cash (Debt) | 889.79 | 1,086 | 807.69 | 988.47 | 717.38 | 402.39 | Upgrade
|
Net Cash Growth | -29.40% | 34.43% | -18.29% | 37.79% | 78.28% | -27.38% | Upgrade
|
Net Cash Per Share | 0.42 | 0.51 | 0.39 | 0.49 | 0.38 | 0.22 | Upgrade
|
Filing Date Shares Outstanding | 2,126 | 2,124 | 2,111 | 2,096 | 1,953 | 1,878 | Upgrade
|
Total Common Shares Outstanding | 2,126 | 2,123 | 2,111 | 2,096 | 1,953 | 1,878 | Upgrade
|
Working Capital | 1,681 | 1,858 | 1,219 | 1,226 | 665.26 | 329.54 | Upgrade
|
Book Value Per Share | 0.57 | 0.66 | 0.48 | 0.50 | 0.46 | 0.20 | Upgrade
|
Tangible Book Value | 1,197 | 1,371 | 984.18 | 1,005 | 861.57 | 342.08 | Upgrade
|
Tangible Book Value Per Share | 0.56 | 0.65 | 0.47 | 0.48 | 0.44 | 0.18 | Upgrade
|
Land | - | 350.49 | 265.52 | 188.58 | 175.82 | 129.43 | Upgrade
|
Machinery | - | 319.62 | 257.2 | 224.78 | 184.07 | 117.57 | Upgrade
|
Construction In Progress | - | 131.6 | 142.06 | 91.22 | 66.44 | 40.32 | Upgrade
|
Order Backlog | - | - | - | - | 94.7 | 49.4 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.